WXXWY:OTCMKTS
Wuxi Biologics Cayman ADR
12,56 US$
arrow_upward
+0,48%(+0,060) 1D
16 okt, 16:00:00 GMT-4 · USD
search
Bütün simvollar
| Simvol | Qiymət | Dəyişiklik | % Dəyişiklik |
|---|
insights_autoWXXWY üçün ən vacib statistik məlumatlar yaradılır...
Açın
12,29 US$
Yüksək
12,56 US$
Aşağı
12,20 US$
Bazar kapitalizasiyası
198,43 mlrd
Ortalama həcm
61,89K
Həcm
110,85K
52 həftəlik ən yüksək
14,80 US$
52 həftəlik ən aşağı
7,30 US$
Beta
0,01
Dövriyyədəki səhmlər
2,06 mlrd
İşçilərin sayı
15K
Açın
12,29 US$
Yüksək
12,56 US$
Aşağı
12,20 US$
Bazar kapitalizasiyası
198,43 mlrd
Ortalama həcm
61,89K
Həcm
110,85K
52 həftəlik ən yüksək
14,80 US$
52 həftəlik ən aşağı
7,30 US$
Beta
0,01
Dövriyyədəki səhmlər
2,06 mlrd
İşçilərin sayı
15K
Xəbər materialları
Veb mənbələri və xəbər partnyorlarından
The Fintech Times
·
18 dəqiqə öncə
First Digital to List on Nasdaq via SPAC Deal at $250m Valuation
Yahoo Finance
·
1 saat öncə
Anthropic IPO Buzz Has Investors Watching Nasdaq Stock And ECM Fee Winners
Bloomberg.com
·
4 saat öncə
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Wuxi Biologics Cayman ADR haqqında
Baş İcraçı DirektorZhisheng Chen
İşçilər14,7K
Təsis Tarixi2010
Baş Ofis-
SektorHealth care
Veb-saytwuxibiologics.com